nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—CHRM3—ureter—urinary bladder cancer	0.076	0.24	CbGeAlD
Ipratropium bromide—CHRM3—muscle of abdomen—urinary bladder cancer	0.0547	0.173	CbGeAlD
Ipratropium bromide—CYP3A4—urine—urinary bladder cancer	0.0136	0.0428	CbGeAlD
Ipratropium bromide—CYP2D6—urine—urinary bladder cancer	0.0134	0.0422	CbGeAlD
Ipratropium bromide—CHRM5—epithelium—urinary bladder cancer	0.0117	0.0368	CbGeAlD
Ipratropium bromide—SLC22A4—prostate gland—urinary bladder cancer	0.0112	0.0354	CbGeAlD
Ipratropium bromide—CHRM2—prostate gland—urinary bladder cancer	0.0109	0.0344	CbGeAlD
Ipratropium bromide—CHRM1—prostate gland—urinary bladder cancer	0.00991	0.0313	CbGeAlD
Ipratropium bromide—SLC22A4—seminal vesicle—urinary bladder cancer	0.0095	0.03	CbGeAlD
Ipratropium bromide—CHRM3—prostate gland—urinary bladder cancer	0.00887	0.028	CbGeAlD
Ipratropium bromide—SLC22A4—renal system—urinary bladder cancer	0.00765	0.0242	CbGeAlD
Ipratropium bromide—SLC22A5—prostate gland—urinary bladder cancer	0.00743	0.0235	CbGeAlD
Ipratropium bromide—SLC22A5—seminal vesicle—urinary bladder cancer	0.00628	0.0198	CbGeAlD
Ipratropium bromide—CHRM3—smooth muscle tissue—urinary bladder cancer	0.00628	0.0198	CbGeAlD
Ipratropium bromide—SLC22A4—female reproductive system—urinary bladder cancer	0.00613	0.0193	CbGeAlD
Ipratropium bromide—CHRM3—renal system—urinary bladder cancer	0.00604	0.0191	CbGeAlD
Ipratropium bromide—CHRM3—urethra—urinary bladder cancer	0.00594	0.0187	CbGeAlD
Ipratropium bromide—SLC22A4—vagina—urinary bladder cancer	0.00554	0.0175	CbGeAlD
Ipratropium bromide—CHRM1—female reproductive system—urinary bladder cancer	0.00541	0.0171	CbGeAlD
Ipratropium bromide—SLC22A5—renal system—urinary bladder cancer	0.00506	0.016	CbGeAlD
Ipratropium bromide—SLC22A5—urethra—urinary bladder cancer	0.00497	0.0157	CbGeAlD
Ipratropium bromide—CHRM3—female reproductive system—urinary bladder cancer	0.00484	0.0153	CbGeAlD
Ipratropium bromide—SLC22A5—female reproductive system—urinary bladder cancer	0.00406	0.0128	CbGeAlD
Ipratropium bromide—SLC22A5—vagina—urinary bladder cancer	0.00367	0.0116	CbGeAlD
Ipratropium bromide—SLC22A4—lymph node—urinary bladder cancer	0.00358	0.0113	CbGeAlD
Ipratropium bromide—CYP3A4—renal system—urinary bladder cancer	0.00332	0.0105	CbGeAlD
Ipratropium bromide—CYP2D6—renal system—urinary bladder cancer	0.00327	0.0103	CbGeAlD
Ipratropium bromide—CYP3A4—female reproductive system—urinary bladder cancer	0.00266	0.00839	CbGeAlD
Ipratropium bromide—CYP2D6—female reproductive system—urinary bladder cancer	0.00262	0.00826	CbGeAlD
Ipratropium bromide—SLC22A5—lymph node—urinary bladder cancer	0.00237	0.00749	CbGeAlD
Ipratropium bromide—Tachycardia—Etoposide—urinary bladder cancer	0.000909	0.00133	CcSEcCtD
Ipratropium bromide—Dyspnoea—Cisplatin—urinary bladder cancer	0.000907	0.00133	CcSEcCtD
Ipratropium bromide—Skin disorder—Etoposide—urinary bladder cancer	0.000905	0.00132	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000901	0.00132	CcSEcCtD
Ipratropium bromide—Diarrhoea—Thiotepa—urinary bladder cancer	0.000887	0.0013	CcSEcCtD
Ipratropium bromide—Bronchitis—Epirubicin—urinary bladder cancer	0.000883	0.00129	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000878	0.00129	CcSEcCtD
Ipratropium bromide—Hypotension—Etoposide—urinary bladder cancer	0.000871	0.00127	CcSEcCtD
Ipratropium bromide—Pain—Cisplatin—urinary bladder cancer	0.00087	0.00127	CcSEcCtD
Ipratropium bromide—Dysuria—Epirubicin—urinary bladder cancer	0.000859	0.00126	CcSEcCtD
Ipratropium bromide—Dizziness—Thiotepa—urinary bladder cancer	0.000858	0.00126	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.000854	0.00125	CcSEcCtD
Ipratropium bromide—Stomatitis—Methotrexate—urinary bladder cancer	0.000853	0.00125	CcSEcCtD
Ipratropium bromide—Urticaria—Fluorouracil—urinary bladder cancer	0.000852	0.00125	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Methotrexate—urinary bladder cancer	0.000851	0.00124	CcSEcCtD
Ipratropium bromide—Influenza—Doxorubicin—urinary bladder cancer	0.00085	0.00124	CcSEcCtD
Ipratropium bromide—Asthma—Doxorubicin—urinary bladder cancer	0.00085	0.00124	CcSEcCtD
Ipratropium bromide—Dysphagia—Doxorubicin—urinary bladder cancer	0.00085	0.00124	CcSEcCtD
Ipratropium bromide—Pollakiuria—Epirubicin—urinary bladder cancer	0.000848	0.00124	CcSEcCtD
Ipratropium bromide—Sweating—Methotrexate—urinary bladder cancer	0.000839	0.00123	CcSEcCtD
Ipratropium bromide—Paraesthesia—Etoposide—urinary bladder cancer	0.000837	0.00122	CcSEcCtD
Ipratropium bromide—Dyspnoea—Etoposide—urinary bladder cancer	0.000831	0.00122	CcSEcCtD
Ipratropium bromide—Somnolence—Etoposide—urinary bladder cancer	0.000828	0.00121	CcSEcCtD
Ipratropium bromide—Epistaxis—Methotrexate—urinary bladder cancer	0.000825	0.00121	CcSEcCtD
Ipratropium bromide—Vomiting—Thiotepa—urinary bladder cancer	0.000825	0.00121	CcSEcCtD
Ipratropium bromide—Rash—Thiotepa—urinary bladder cancer	0.000818	0.0012	CcSEcCtD
Ipratropium bromide—Bronchitis—Doxorubicin—urinary bladder cancer	0.000817	0.0012	CcSEcCtD
Ipratropium bromide—Dermatitis—Thiotepa—urinary bladder cancer	0.000817	0.0012	CcSEcCtD
Ipratropium bromide—Headache—Thiotepa—urinary bladder cancer	0.000813	0.00119	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000804	0.00118	CcSEcCtD
Ipratropium bromide—Fatigue—Etoposide—urinary bladder cancer	0.000803	0.00118	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000803	0.00117	CcSEcCtD
Ipratropium bromide—Stomatitis—Epirubicin—urinary bladder cancer	0.000798	0.00117	CcSEcCtD
Ipratropium bromide—Pain—Etoposide—urinary bladder cancer	0.000797	0.00117	CcSEcCtD
Ipratropium bromide—Constipation—Etoposide—urinary bladder cancer	0.000797	0.00117	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000796	0.00116	CcSEcCtD
Ipratropium bromide—Urinary tract infection—Epirubicin—urinary bladder cancer	0.000796	0.00116	CcSEcCtD
Ipratropium bromide—Dysuria—Doxorubicin—urinary bladder cancer	0.000795	0.00116	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00079	0.00116	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.00079	0.00116	CcSEcCtD
Ipratropium bromide—Haemoglobin—Methotrexate—urinary bladder cancer	0.000789	0.00116	CcSEcCtD
Ipratropium bromide—Haemorrhage—Methotrexate—urinary bladder cancer	0.000785	0.00115	CcSEcCtD
Ipratropium bromide—Sweating—Epirubicin—urinary bladder cancer	0.000785	0.00115	CcSEcCtD
Ipratropium bromide—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000785	0.00115	CcSEcCtD
Ipratropium bromide—Asthenia—Gemcitabine—urinary bladder cancer	0.000783	0.00115	CcSEcCtD
Ipratropium bromide—Pharyngitis—Methotrexate—urinary bladder cancer	0.00078	0.00114	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000776	0.00114	CcSEcCtD
Ipratropium bromide—Epistaxis—Epirubicin—urinary bladder cancer	0.000772	0.00113	CcSEcCtD
Ipratropium bromide—Pruritus—Gemcitabine—urinary bladder cancer	0.000772	0.00113	CcSEcCtD
Ipratropium bromide—Nausea—Thiotepa—urinary bladder cancer	0.00077	0.00113	CcSEcCtD
Ipratropium bromide—Urethral disorder—Methotrexate—urinary bladder cancer	0.00077	0.00113	CcSEcCtD
Ipratropium bromide—Sinusitis—Epirubicin—urinary bladder cancer	0.000768	0.00112	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000762	0.00112	CcSEcCtD
Ipratropium bromide—Pruritus—Fluorouracil—urinary bladder cancer	0.000759	0.00111	CcSEcCtD
Ipratropium bromide—Visual impairment—Methotrexate—urinary bladder cancer	0.000757	0.00111	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000749	0.0011	CcSEcCtD
Ipratropium bromide—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000747	0.00109	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000743	0.00109	CcSEcCtD
Ipratropium bromide—Urticaria—Etoposide—urinary bladder cancer	0.00074	0.00108	CcSEcCtD
Ipratropium bromide—Haemoglobin—Epirubicin—urinary bladder cancer	0.000739	0.00108	CcSEcCtD
Ipratropium bromide—Stomatitis—Doxorubicin—urinary bladder cancer	0.000739	0.00108	CcSEcCtD
Ipratropium bromide—Rhinitis—Epirubicin—urinary bladder cancer	0.000737	0.00108	CcSEcCtD
Ipratropium bromide—Abdominal pain—Etoposide—urinary bladder cancer	0.000736	0.00108	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000736	0.00108	CcSEcCtD
Ipratropium bromide—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000736	0.00108	CcSEcCtD
Ipratropium bromide—Haemorrhage—Epirubicin—urinary bladder cancer	0.000735	0.00108	CcSEcCtD
Ipratropium bromide—Eye disorder—Methotrexate—urinary bladder cancer	0.000734	0.00107	CcSEcCtD
Ipratropium bromide—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000734	0.00107	CcSEcCtD
Ipratropium bromide—Tinnitus—Methotrexate—urinary bladder cancer	0.000732	0.00107	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000731	0.00107	CcSEcCtD
Ipratropium bromide—Asthenia—Cisplatin—urinary bladder cancer	0.00073	0.00107	CcSEcCtD
Ipratropium bromide—Pharyngitis—Epirubicin—urinary bladder cancer	0.00073	0.00107	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000729	0.00107	CcSEcCtD
Ipratropium bromide—Sweating—Doxorubicin—urinary bladder cancer	0.000726	0.00106	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000726	0.00106	CcSEcCtD
Ipratropium bromide—Urethral disorder—Epirubicin—urinary bladder cancer	0.000721	0.00105	CcSEcCtD
Ipratropium bromide—Epistaxis—Doxorubicin—urinary bladder cancer	0.000715	0.00105	CcSEcCtD
Ipratropium bromide—Sinusitis—Doxorubicin—urinary bladder cancer	0.000711	0.00104	CcSEcCtD
Ipratropium bromide—Immune system disorder—Methotrexate—urinary bladder cancer	0.000709	0.00104	CcSEcCtD
Ipratropium bromide—Dizziness—Fluorouracil—urinary bladder cancer	0.000709	0.00104	CcSEcCtD
Ipratropium bromide—Visual impairment—Epirubicin—urinary bladder cancer	0.000708	0.00104	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000708	0.00104	CcSEcCtD
Ipratropium bromide—Diarrhoea—Cisplatin—urinary bladder cancer	0.000696	0.00102	CcSEcCtD
Ipratropium bromide—Vomiting—Gemcitabine—urinary bladder cancer	0.000694	0.00102	CcSEcCtD
Ipratropium bromide—Rash—Gemcitabine—urinary bladder cancer	0.000688	0.00101	CcSEcCtD
Ipratropium bromide—Dermatitis—Gemcitabine—urinary bladder cancer	0.000687	0.00101	CcSEcCtD
Ipratropium bromide—Eye disorder—Epirubicin—urinary bladder cancer	0.000687	0.00101	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Etoposide—urinary bladder cancer	0.000686	0.001	CcSEcCtD
Ipratropium bromide—Tinnitus—Epirubicin—urinary bladder cancer	0.000685	0.001	CcSEcCtD
Ipratropium bromide—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000684	0.001	CcSEcCtD
Ipratropium bromide—Headache—Gemcitabine—urinary bladder cancer	0.000684	0.001	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000682	0.000999	CcSEcCtD
Ipratropium bromide—Flushing—Epirubicin—urinary bladder cancer	0.000682	0.000999	CcSEcCtD
Ipratropium bromide—Vomiting—Fluorouracil—urinary bladder cancer	0.000682	0.000998	CcSEcCtD
Ipratropium bromide—Rhinitis—Doxorubicin—urinary bladder cancer	0.000682	0.000998	CcSEcCtD
Ipratropium bromide—Haemorrhage—Doxorubicin—urinary bladder cancer	0.00068	0.000995	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000677	0.00099	CcSEcCtD
Ipratropium bromide—Rash—Fluorouracil—urinary bladder cancer	0.000676	0.00099	CcSEcCtD
Ipratropium bromide—Dermatitis—Fluorouracil—urinary bladder cancer	0.000676	0.000989	CcSEcCtD
Ipratropium bromide—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000675	0.000988	CcSEcCtD
Ipratropium bromide—Headache—Fluorouracil—urinary bladder cancer	0.000672	0.000984	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000672	0.000983	CcSEcCtD
Ipratropium bromide—Dysgeusia—Methotrexate—urinary bladder cancer	0.00067	0.00098	CcSEcCtD
Ipratropium bromide—Asthenia—Etoposide—urinary bladder cancer	0.000668	0.000978	CcSEcCtD
Ipratropium bromide—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000667	0.000976	CcSEcCtD
Ipratropium bromide—Immune system disorder—Epirubicin—urinary bladder cancer	0.000664	0.000972	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000662	0.00097	CcSEcCtD
Ipratropium bromide—Back pain—Methotrexate—urinary bladder cancer	0.000661	0.000968	CcSEcCtD
Ipratropium bromide—Pruritus—Etoposide—urinary bladder cancer	0.000659	0.000965	CcSEcCtD
Ipratropium bromide—Visual impairment—Doxorubicin—urinary bladder cancer	0.000655	0.000959	CcSEcCtD
Ipratropium bromide—Nausea—Gemcitabine—urinary bladder cancer	0.000648	0.000949	CcSEcCtD
Ipratropium bromide—Vomiting—Cisplatin—urinary bladder cancer	0.000647	0.000946	CcSEcCtD
Ipratropium bromide—Vision blurred—Methotrexate—urinary bladder cancer	0.000644	0.000943	CcSEcCtD
Ipratropium bromide—Rash—Cisplatin—urinary bladder cancer	0.000641	0.000938	CcSEcCtD
Ipratropium bromide—Dermatitis—Cisplatin—urinary bladder cancer	0.000641	0.000938	CcSEcCtD
Ipratropium bromide—Diarrhoea—Etoposide—urinary bladder cancer	0.000637	0.000933	CcSEcCtD
Ipratropium bromide—Nausea—Fluorouracil—urinary bladder cancer	0.000637	0.000933	CcSEcCtD
Ipratropium bromide—Eye disorder—Doxorubicin—urinary bladder cancer	0.000636	0.00093	CcSEcCtD
Ipratropium bromide—Tinnitus—Doxorubicin—urinary bladder cancer	0.000634	0.000928	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000631	0.000924	CcSEcCtD
Ipratropium bromide—Flushing—Doxorubicin—urinary bladder cancer	0.000631	0.000924	CcSEcCtD
Ipratropium bromide—Flatulence—Epirubicin—urinary bladder cancer	0.000631	0.000923	CcSEcCtD
Ipratropium bromide—Tension—Epirubicin—urinary bladder cancer	0.000628	0.000919	CcSEcCtD
Ipratropium bromide—Dysgeusia—Epirubicin—urinary bladder cancer	0.000627	0.000917	CcSEcCtD
Ipratropium bromide—Nervousness—Epirubicin—urinary bladder cancer	0.000622	0.00091	CcSEcCtD
Ipratropium bromide—Back pain—Epirubicin—urinary bladder cancer	0.000619	0.000906	CcSEcCtD
Ipratropium bromide—Dizziness—Etoposide—urinary bladder cancer	0.000616	0.000902	CcSEcCtD
Ipratropium bromide—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000614	0.000899	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000613	0.000897	CcSEcCtD
Ipratropium bromide—Nausea—Cisplatin—urinary bladder cancer	0.000604	0.000884	CcSEcCtD
Ipratropium bromide—Vision blurred—Epirubicin—urinary bladder cancer	0.000603	0.000883	CcSEcCtD
Ipratropium bromide—Cough—Methotrexate—urinary bladder cancer	0.000597	0.000873	CcSEcCtD
Ipratropium bromide—Vomiting—Etoposide—urinary bladder cancer	0.000592	0.000867	CcSEcCtD
Ipratropium bromide—Rash—Etoposide—urinary bladder cancer	0.000587	0.00086	CcSEcCtD
Ipratropium bromide—Dermatitis—Etoposide—urinary bladder cancer	0.000587	0.000859	CcSEcCtD
Ipratropium bromide—Headache—Etoposide—urinary bladder cancer	0.000584	0.000854	CcSEcCtD
Ipratropium bromide—Flatulence—Doxorubicin—urinary bladder cancer	0.000583	0.000854	CcSEcCtD
Ipratropium bromide—Chest pain—Methotrexate—urinary bladder cancer	0.000582	0.000852	CcSEcCtD
Ipratropium bromide—Myalgia—Methotrexate—urinary bladder cancer	0.000582	0.000852	CcSEcCtD
Ipratropium bromide—Tension—Doxorubicin—urinary bladder cancer	0.000581	0.00085	CcSEcCtD
Ipratropium bromide—Dysgeusia—Doxorubicin—urinary bladder cancer	0.00058	0.000849	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000578	0.000846	CcSEcCtD
Ipratropium bromide—Nervousness—Doxorubicin—urinary bladder cancer	0.000575	0.000842	CcSEcCtD
Ipratropium bromide—Back pain—Doxorubicin—urinary bladder cancer	0.000573	0.000838	CcSEcCtD
Ipratropium bromide—Palpitations—Epirubicin—urinary bladder cancer	0.000565	0.000828	CcSEcCtD
Ipratropium bromide—Cough—Epirubicin—urinary bladder cancer	0.000558	0.000817	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000558	0.000817	CcSEcCtD
Ipratropium bromide—Vision blurred—Doxorubicin—urinary bladder cancer	0.000558	0.000817	CcSEcCtD
Ipratropium bromide—Infection—Methotrexate—urinary bladder cancer	0.000554	0.000811	CcSEcCtD
Ipratropium bromide—Nausea—Etoposide—urinary bladder cancer	0.000553	0.00081	CcSEcCtD
Ipratropium bromide—Hypertension—Epirubicin—urinary bladder cancer	0.000552	0.000809	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000547	0.000801	CcSEcCtD
Ipratropium bromide—Chest pain—Epirubicin—urinary bladder cancer	0.000545	0.000797	CcSEcCtD
Ipratropium bromide—Myalgia—Epirubicin—urinary bladder cancer	0.000545	0.000797	CcSEcCtD
Ipratropium bromide—Skin disorder—Methotrexate—urinary bladder cancer	0.000542	0.000793	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000541	0.000792	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000539	0.00079	CcSEcCtD
Ipratropium bromide—Dry mouth—Epirubicin—urinary bladder cancer	0.000533	0.00078	CcSEcCtD
Ipratropium bromide—Palpitations—Doxorubicin—urinary bladder cancer	0.000523	0.000766	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000522	0.000764	CcSEcCtD
Ipratropium bromide—Oedema—Epirubicin—urinary bladder cancer	0.000522	0.000764	CcSEcCtD
Ipratropium bromide—Hypotension—Methotrexate—urinary bladder cancer	0.000521	0.000763	CcSEcCtD
Ipratropium bromide—Infection—Epirubicin—urinary bladder cancer	0.000519	0.000759	CcSEcCtD
Ipratropium bromide—Cough—Doxorubicin—urinary bladder cancer	0.000517	0.000756	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000512	0.00075	CcSEcCtD
Ipratropium bromide—Hypertension—Doxorubicin—urinary bladder cancer	0.000511	0.000748	CcSEcCtD
Ipratropium bromide—Tachycardia—Epirubicin—urinary bladder cancer	0.00051	0.000746	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000508	0.000744	CcSEcCtD
Ipratropium bromide—Skin disorder—Epirubicin—urinary bladder cancer	0.000507	0.000742	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000505	0.000739	CcSEcCtD
Ipratropium bromide—Insomnia—Methotrexate—urinary bladder cancer	0.000505	0.000739	CcSEcCtD
Ipratropium bromide—Chest pain—Doxorubicin—urinary bladder cancer	0.000504	0.000738	CcSEcCtD
Ipratropium bromide—Myalgia—Doxorubicin—urinary bladder cancer	0.000504	0.000738	CcSEcCtD
Ipratropium bromide—Paraesthesia—Methotrexate—urinary bladder cancer	0.000501	0.000733	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000501	0.000733	CcSEcCtD
Ipratropium bromide—Dyspnoea—Methotrexate—urinary bladder cancer	0.000498	0.000728	CcSEcCtD
Ipratropium bromide—Somnolence—Methotrexate—urinary bladder cancer	0.000496	0.000726	CcSEcCtD
Ipratropium bromide—Dry mouth—Doxorubicin—urinary bladder cancer	0.000493	0.000722	CcSEcCtD
Ipratropium bromide—Dyspepsia—Methotrexate—urinary bladder cancer	0.000491	0.000719	CcSEcCtD
Ipratropium bromide—Hypotension—Epirubicin—urinary bladder cancer	0.000488	0.000714	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000483	0.000707	CcSEcCtD
Ipratropium bromide—Oedema—Doxorubicin—urinary bladder cancer	0.000483	0.000707	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000482	0.000705	CcSEcCtD
Ipratropium bromide—Fatigue—Methotrexate—urinary bladder cancer	0.000481	0.000704	CcSEcCtD
Ipratropium bromide—Infection—Doxorubicin—urinary bladder cancer	0.00048	0.000703	CcSEcCtD
Ipratropium bromide—Pain—Methotrexate—urinary bladder cancer	0.000477	0.000698	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000476	0.000696	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000474	0.000694	CcSEcCtD
Ipratropium bromide—Insomnia—Epirubicin—urinary bladder cancer	0.000472	0.000691	CcSEcCtD
Ipratropium bromide—Tachycardia—Doxorubicin—urinary bladder cancer	0.000472	0.00069	CcSEcCtD
Ipratropium bromide—Skin disorder—Doxorubicin—urinary bladder cancer	0.000469	0.000687	CcSEcCtD
Ipratropium bromide—Paraesthesia—Epirubicin—urinary bladder cancer	0.000469	0.000686	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000467	0.000684	CcSEcCtD
Ipratropium bromide—Dyspnoea—Epirubicin—urinary bladder cancer	0.000466	0.000681	CcSEcCtD
Ipratropium bromide—Somnolence—Epirubicin—urinary bladder cancer	0.000464	0.00068	CcSEcCtD
Ipratropium bromide—Dyspepsia—Epirubicin—urinary bladder cancer	0.00046	0.000673	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000456	0.000668	CcSEcCtD
Ipratropium bromide—Hypotension—Doxorubicin—urinary bladder cancer	0.000452	0.000661	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000451	0.00066	CcSEcCtD
Ipratropium bromide—Fatigue—Epirubicin—urinary bladder cancer	0.00045	0.000659	CcSEcCtD
Ipratropium bromide—Pain—Epirubicin—urinary bladder cancer	0.000447	0.000654	CcSEcCtD
Ipratropium bromide—Constipation—Epirubicin—urinary bladder cancer	0.000447	0.000654	CcSEcCtD
Ipratropium bromide—Urticaria—Methotrexate—urinary bladder cancer	0.000443	0.000649	CcSEcCtD
Ipratropium bromide—Abdominal pain—Methotrexate—urinary bladder cancer	0.000441	0.000646	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.00044	0.000644	CcSEcCtD
Ipratropium bromide—Insomnia—Doxorubicin—urinary bladder cancer	0.000437	0.00064	CcSEcCtD
Ipratropium bromide—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000434	0.000635	CcSEcCtD
Ipratropium bromide—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000431	0.000631	CcSEcCtD
Ipratropium bromide—Somnolence—Doxorubicin—urinary bladder cancer	0.00043	0.000629	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000427	0.000625	CcSEcCtD
Ipratropium bromide—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000425	0.000623	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000417	0.000611	CcSEcCtD
Ipratropium bromide—Fatigue—Doxorubicin—urinary bladder cancer	0.000417	0.00061	CcSEcCtD
Ipratropium bromide—Urticaria—Epirubicin—urinary bladder cancer	0.000415	0.000607	CcSEcCtD
Ipratropium bromide—Pain—Doxorubicin—urinary bladder cancer	0.000413	0.000605	CcSEcCtD
Ipratropium bromide—Constipation—Doxorubicin—urinary bladder cancer	0.000413	0.000605	CcSEcCtD
Ipratropium bromide—Abdominal pain—Epirubicin—urinary bladder cancer	0.000413	0.000604	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000411	0.000602	CcSEcCtD
Ipratropium bromide—Asthenia—Methotrexate—urinary bladder cancer	0.0004	0.000586	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000395	0.000578	CcSEcCtD
Ipratropium bromide—Pruritus—Methotrexate—urinary bladder cancer	0.000395	0.000578	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000385	0.000563	CcSEcCtD
Ipratropium bromide—Urticaria—Doxorubicin—urinary bladder cancer	0.000384	0.000562	CcSEcCtD
Ipratropium bromide—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000382	0.000559	CcSEcCtD
Ipratropium bromide—Diarrhoea—Methotrexate—urinary bladder cancer	0.000382	0.000559	CcSEcCtD
Ipratropium bromide—Asthenia—Epirubicin—urinary bladder cancer	0.000375	0.000548	CcSEcCtD
Ipratropium bromide—Pruritus—Epirubicin—urinary bladder cancer	0.000369	0.000541	CcSEcCtD
Ipratropium bromide—Dizziness—Methotrexate—urinary bladder cancer	0.000369	0.00054	CcSEcCtD
Ipratropium bromide—Diarrhoea—Epirubicin—urinary bladder cancer	0.000357	0.000523	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000356	0.000521	CcSEcCtD
Ipratropium bromide—Vomiting—Methotrexate—urinary bladder cancer	0.000355	0.000519	CcSEcCtD
Ipratropium bromide—Rash—Methotrexate—urinary bladder cancer	0.000352	0.000515	CcSEcCtD
Ipratropium bromide—Dermatitis—Methotrexate—urinary bladder cancer	0.000352	0.000515	CcSEcCtD
Ipratropium bromide—Headache—Methotrexate—urinary bladder cancer	0.00035	0.000512	CcSEcCtD
Ipratropium bromide—Asthenia—Doxorubicin—urinary bladder cancer	0.000347	0.000507	CcSEcCtD
Ipratropium bromide—Dizziness—Epirubicin—urinary bladder cancer	0.000345	0.000505	CcSEcCtD
Ipratropium bromide—Pruritus—Doxorubicin—urinary bladder cancer	0.000342	0.0005	CcSEcCtD
Ipratropium bromide—Vomiting—Epirubicin—urinary bladder cancer	0.000332	0.000486	CcSEcCtD
Ipratropium bromide—Nausea—Methotrexate—urinary bladder cancer	0.000331	0.000485	CcSEcCtD
Ipratropium bromide—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000331	0.000484	CcSEcCtD
Ipratropium bromide—Rash—Epirubicin—urinary bladder cancer	0.000329	0.000482	CcSEcCtD
Ipratropium bromide—Dermatitis—Epirubicin—urinary bladder cancer	0.000329	0.000482	CcSEcCtD
Ipratropium bromide—Headache—Epirubicin—urinary bladder cancer	0.000327	0.000479	CcSEcCtD
Ipratropium bromide—Dizziness—Doxorubicin—urinary bladder cancer	0.00032	0.000468	CcSEcCtD
Ipratropium bromide—Nausea—Epirubicin—urinary bladder cancer	0.00031	0.000454	CcSEcCtD
Ipratropium bromide—Vomiting—Doxorubicin—urinary bladder cancer	0.000307	0.00045	CcSEcCtD
Ipratropium bromide—Rash—Doxorubicin—urinary bladder cancer	0.000305	0.000446	CcSEcCtD
Ipratropium bromide—Dermatitis—Doxorubicin—urinary bladder cancer	0.000304	0.000446	CcSEcCtD
Ipratropium bromide—Headache—Doxorubicin—urinary bladder cancer	0.000303	0.000443	CcSEcCtD
Ipratropium bromide—Nausea—Doxorubicin—urinary bladder cancer	0.000287	0.00042	CcSEcCtD
